106 related articles for article (PubMed ID: 2116398)
1. Epidermal growth factor prolongs survival time of tumor-bearing mice.
Amagase H; Tamura K; Okuhira M; Kakimoto M; Amano H; Hashimoto K; Fuwa T; Tsukagoshi S
Jpn J Cancer Res; 1990 May; 81(5):495-500. PubMed ID: 2116398
[TBL] [Abstract][Full Text] [Related]
2. Response of A431 experimental human solid xenograft to mitomycin C in combination with human epidermal growth factor in mice.
Amagase H; Tamura K; Hashimoto K; Fuwa T; Murakami T; Yata N
J Pharmacobiodyn; 1990 Apr; 13(4):263-8. PubMed ID: 2117064
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
Masui H; Kawamoto T; Sato JD; Wolf B; Sato G; Mendelsohn J
Cancer Res; 1984 Mar; 44(3):1002-7. PubMed ID: 6318979
[TBL] [Abstract][Full Text] [Related]
5. Quantitative differences in the effects of mouse and human epidermal growth factors on A431 human tumor cells.
Connolly JM; Rose DP
Cancer Lett; 1987 Nov; 37(3):241-9. PubMed ID: 3499972
[TBL] [Abstract][Full Text] [Related]
6. Effect of human epidermal growth factor on cell growth and its receptor in human gastric carcinoma cell lines.
Ochiai A; Takanashi A; Takekura N; Yoshida K; Miyamori S; Harada T; Tahara E
Jpn J Clin Oncol; 1988 Mar; 18(1):15-25. PubMed ID: 3258388
[TBL] [Abstract][Full Text] [Related]
7. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
[TBL] [Abstract][Full Text] [Related]
8. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J
J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor.
Cornelissen B; Kersemans V; Burvenich I; Oltenfreiter R; Vanderheyden JL; Boerman O; Vandewiele C; Slegers G
Nucl Med Commun; 2005 Feb; 26(2):147-53. PubMed ID: 15657509
[TBL] [Abstract][Full Text] [Related]
10. Gefitinib enhances radiotherapeutic effects of
Xia L; Peng H; Zhiqiang L; Xiaoli Z
Nucl Med Biol; 2017 May; 48():63-68. PubMed ID: 28254656
[TBL] [Abstract][Full Text] [Related]
11. Fusion of the CH1 domain of IgG1 to epidermal growth factor (EGF) prolongs its retention in the blood but does not increase tumor uptake.
Wang J; Reilly RM; Chen P; Yang S; Bray MR; Gariépy J; Chan C; Sandhu J
Cancer Biother Radiopharm; 2002 Dec; 17(6):665-71. PubMed ID: 12537670
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function.
Zolfaghari A; Djakiew D
Prostate; 1996 Apr; 28(4):232-8. PubMed ID: 8602399
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor stimulates the growth of A431 tumors in athymic mice.
Ginsburg E; Vonderhaar BK
Cancer Lett; 1985 Sep; 28(2):143-50. PubMed ID: 3876879
[TBL] [Abstract][Full Text] [Related]
14. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.
Kawamoto T; Sato JD; Le A; Polikoff J; Sato GH; Mendelsohn J
Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1337-41. PubMed ID: 6298788
[TBL] [Abstract][Full Text] [Related]
15. Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy.
Tahara E; Sumiyoshi H; Hata J; Yasui W; Taniyama K; Hayashi T; Nagae S; Sakamoto S
Jpn J Cancer Res; 1986 Feb; 77(2):145-52. PubMed ID: 2420773
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of human nasopharyngeal carcinoma in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
Guan E; Zhou TC; Wang JH; Huang PG; Tang WP; Zhao ML; Chen Y; Sun YX
Int J Cell Cloning; 1989 Jul; 7(4):242-56. PubMed ID: 2768842
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of the growth-inhibitory effect of the RNase-EGF fused protein against EGFR-overexpressing cells.
Hoshimoto S; Ueda M; Jinno H; Kitajima M; Futami J; Seno M
Anticancer Res; 2006; 26(2A):857-63. PubMed ID: 16619480
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor-mediated selective cytotoxicity of antitumor agents toward human xenografts and murine syngeneic solid tumors.
Amagase H; Kakimoto M; Hashimoto K; Fuwa T; Tsukagoshi S
Jpn J Cancer Res; 1989 Jul; 80(7):670-8. PubMed ID: 2507490
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.
Velikyan I; Sundberg AL; Lindhe O; Höglund AU; Eriksson O; Werner E; Carlsson J; Bergström M; Långström B; Tolmachev V
J Nucl Med; 2005 Nov; 46(11):1881-8. PubMed ID: 16269603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
